Overview

Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects

Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
To investigate the Pharmacokinetics (PK) of transdermally delivered Rotigotine in Japanese and Caucasian Female and Male Healthy Subjects.
Phase:
Phase 1
Details
Lead Sponsor:
UCB BIOSCIENCES GmbH
Collaborators:
40789 Monheim am Rhein
Alfred-Nobel-Str. 10
Schwarz BioSciences GmbH
Treatments:
N 0437
Rotigotine